Service de Chirurgie Digestive, Oncologique, Endocrinienne et Transplantation Hépatique, CHRU de TOURS
Tours, 37044, France
NCT Number: NCT03371537
Hepatocellular insufficiency is a dreaded complication after hepatectomy, since, if it is persistent, it leads to the death of the patient in the absence of liver transplantation.
The preoperative evaluation aims in particular to estimate the risk of postoperative hepatocellular insufficiency so as to minimize or contraindicate high-risk patients.
It has been shown that the flow of the portal vein is correlated with liver function, especially in the living donor and after portal embolization. More recently, the study of flow rates in the portal vein and the hepatic artery after transplantation has shown a correlation with the recovery of graft function.
The hypothesis is that portal and arterial flow after hepatectomy can predict postoperative hepatocellular function.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Tours, 37044, France
Measurements of flow rates in the portal vein and the hepatic artery by different transit times are available thanks to the Medistim VeriQTM system that the investigators already use routinely in the context of liver transplantation when performing hepatectomies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mesure of liver debit during hepatectomy
Time frame: Baseline
Mesure of liver debit during hepatectomy
University Hospital, Tours
Other
Acronym: DEBIFOIE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07541807
Digestive System Diseases, Liver Diseases
Sheffield, United Kingdom
View Trial DetailsNCT04618692
Digestive System Diseases, Digestive System Neoplasms
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06486805
Digestive System Diseases, Liver Diseases
Cairo, Egypt
View Trial DetailsNCT06793007
Digestive System Diseases, Liver Diseases
Kathmandu, Bagmati, Nepal
View Trial Details